Temozolomide and unusual indications: review of literature.
about
Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesIrinotecan and temozolamide treatment for relapsed Ewing sarcoma: a single-center experience and review of the literature.Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center.A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastomaPhase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanomaAnalyzing temozolomide medication errors: potentially fatalAdvances in understanding pituitary tumorsIntracranial meningeal hemangiopericytoma: Recurrences at the initial and distant intracranial sites and extraneural metastases to multiple organs.Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastomaCombined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.Central diabetes insipidus: a previously unreported side effect of temozolomide.New derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo study.Temozolomide: Anti-tumor effect on giant, invasive and resistant pediatric prolactinoma.Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.Metastatic melanoma - a review of current and future drugsOccipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art.The safety of treatments for prolactinomas.MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.Treatment of aggressive prolactinoma with temozolomide: A case report and review of literature up to date.Temozolomide-perillyl alcohol conjugate downregulates O6-methylguanin DNA methltransferase via inducing ubiquitination-dependent proteolysis in non-small cell lung cancer.Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.Synthesis of [3-N-(11) C-methyl]temozolomide via in situ activation of 3-N-hydroxymethyl temozolomide and alkylation with [(11) C]methyl iodide.Quality of life and efficacy of temozolomide combined with whole-brain radiotherapy in patients with brain metastases from non-small-cell lung cancer.
P2860
Q26784162-10E5B09F-E08B-4C30-9D32-8966483DD289Q28072442-CC47262E-21EC-41D9-960B-FAD3E6D4138EQ33417823-932BEB12-B9AA-458D-95D2-E93E738DFBC5Q33419582-A9654959-6628-4DDD-880E-B46EC359E716Q34346483-8FB72F39-8F0B-4147-8727-5AD1D9E56F04Q34372972-D56E3992-F94E-4CE1-BE66-7666C961BCC0Q34443355-83A53931-37F1-4473-A082-88111BC7AD9FQ34660143-B8C05DCC-85A0-4C91-98DD-98C2D491E85EQ35803588-CC1E5892-E2E4-4425-9848-C385D3415FF2Q36145632-0DE5CCF3-4ED2-44A4-831D-DF8586055F53Q36372763-0D1A581E-5441-4324-9040-0B48D936F6EAQ36875981-F61105AF-8068-45A1-8242-56C6C97AF620Q37215472-172ECCF2-4C36-4B46-808D-B5C97D9B12F9Q37237139-C36AF5E7-1A40-4666-8E11-EFE2ECF18EB5Q37413985-03CEF11A-EF45-4009-A344-DD44F7B82F6EQ37419856-71E1A61E-E3C7-44CE-9131-D051720F227EQ37450733-64B3FCDC-5161-4DD2-A43A-FB5E7720DCFEQ37619035-5C7EC8D5-7D2F-4D75-9C15-3ADBC27DA312Q37692451-4521CE61-FB3A-4ACB-A0E7-75F1B603C6F4Q38557054-62F7B66A-3C9F-4764-A69A-EFF112D3376FQ38726058-493896B1-17B2-4E71-8E53-F18D281648E0Q38787480-D0348653-69A7-4087-A829-6A9A70C9EEA5Q44722770-74C3AEFE-EDBB-4DCF-B5F4-0D3C243E7DE6Q47115174-27C59C67-359D-4CD6-9CD2-0372F4B2BAF0Q50091180-EE871403-F60C-4C4C-B5DB-8C9AFD52C290Q53629828-A0364302-8DA9-470B-A3D2-4041B7B64651Q54207869-68C9CEB3-CAB8-44BE-9021-7AD26DD95EFAQ55460168-BB95E1AC-81FA-4141-AADD-5CBBFF128064Q55518797-F027189C-F5CD-414A-BAB9-C8E9A3578842
P2860
Temozolomide and unusual indications: review of literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Temozolomide and unusual indications: review of literature.
@en
type
label
Temozolomide and unusual indications: review of literature.
@en
prefLabel
Temozolomide and unusual indications: review of literature.
@en
P2093
P50
P1476
Temozolomide and unusual indications: review of literature
@en
P2093
Eloise Planchat
Emilie Gadea
Pierre Gimbergues
Zuzana Tatar
P304
P356
10.1016/J.CTRV.2012.06.002
P577
2012-07-19T00:00:00Z